Palantir pays prime-contractor prices in Washington while Europe's armies say no
Q3 lobbying disclosures show $3.1 million on Capitol Hill, a second straight heavy quarter, the same week Barclays filed Palantir under defense primes with a $265 target. The multiple rests on the US government book Europe's armies keep refusing.
Vincent Jiang · 2 min read
Two filings landed this week and they describe one company playing two games at once. Palantir−0.14% — Palantir, down 0.14 percent today reported $3.1 million in federal lobbying for the third quarter of 2026, a second straight heavy quarter and roughly $1.15 million more than a year earlier, per disclosures Punchbowl News flagged on October 22 12. The same week, Barclays−1.48% — Barclays, down 1.48 percent today opened formal coverage of Palantir at Overweight, $265 a share, inside a new aerospace-and-defense launch alongside SpaceX+1.49% — SpaceX, up 1.49 percent today, Boeing+0.28% — Boeing, up 0.28 percent today and RTX 12. A software firm is now filed, and paid, like a defense prime.
The government book carries the 110x multiple
What the lobbying defends is the one large market staying open. US government revenue hit $809 million in Q2 2026, up 90% year over year, sitting on a $10 billion, ten-year Army enterprise agreement, with TITAN entering production and Maven now a Program of Record 23. Wall Street noticed: Goldman Sachs−1.12% — Goldman Sachs, down 1.12 percent today upgraded to Buy on October 8 with a $230 target, arguing the moat compounds into a bigger addressable market 3. The stock closed a record $209.05 on October 9 at roughly 110 times forward earnings, up from 74 times in June 2.
The trap sits in the calendar. Palantir guided Q3 revenue to $2.160–$2.164 billion; the Street's ~$2.18 billion sits just 0.6% above the top, and the company beat its own guide by 5.7% to 8.7% over five quarters 2. Shares still fell after two of those prints 2.
Wall Street targets now sit above a record $209 price
Data
| Price target | |
|---|---|
| Record close 9 Oct | 209.05 |
| Street mean | 200.88 |
| Goldman target | 230 |
| Barclays target | 265 |
The customer Palantir cannot lobby
Europe is the other flank. The Swiss army considered Palantir five times and refused five times, three over lack of control of confidential data, an investigation by Republik and WAV shows 5. France and Germany declined Maven nationally, and on October 22 Palantir's Louis Mosley told NATO allies the company has no kill switch on the system, that neither Palantir nor the US government can remotely disable it 46.
Goldman's own stated risk is that congressional changes could shift government contract win rates 3. The Q3 disclosures show Palantir paying prime-contractor prices to protect the book that a 110x multiple rests on 3. The test comes November 2, when the numbers must clear a bar set barely above guidance 3.
What happens next
PLTRDoes Q3 revenue clear the Street's ~$2.18 billion, barely above the $2.160–$2.164 billion guide?
The case for
US government revenue of $809 million in Q2 2026, up 90% year over year, is the one large market staying open, and Goldman argues the moat compounds into a bigger addressable market
The case against
European rejections are structural, not lobbying gaps: the Swiss army refused Palantir five times and Paris and Berlin declined Maven, while Mosley confirmed there is no kill switch to offer
- Mon Nov 2, 2026Palantir reports third-quarter results.
Get our follow-up when these land
Free. We'll email you when we publish on Palantir, and send our free weekday newsletter. Unfollow in one click.
